PTGX · Protagonist Therapeutics, Inc · Documents
$138.96
+4.52 (+3.36%)
At close · Oct 20
Return incl. dividend (before tax)
Market Cap
$8.70B
Shares
64.71M
Volume · Oct 20
411.23K
Avg daily vol (3M)
636.56K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2020-12-11 | 2020-12-10 | |
| S-3ASR | — | 2020-12-10 | — | |
| 8-K | — | 2020-11-04 | — | |
| 10-Q | — | 2020-11-04 | 2020-09-30 | |
| 8-K/A | — | 2020-10-02 | 2020-08-11 | |
| 8-K | — | 2020-09-11 | — | |
| 8-K | — | 2020-08-13 | 2020-08-11 | |
| 8-K | — | 2020-08-06 | — | |
| 10-Q | — | 2020-08-06 | 2020-06-30 | |
| 8-K | — | 2020-05-29 | 2020-05-28 | |
| 8-K | — | 2020-05-12 | 2020-05-11 | |
| 8-K | — | 2020-05-07 | — | |
| 10-Q | — | 2020-05-07 | 2020-03-31 | |
| DEFA14A | — | 2020-04-16 | — | |
| DEF 14A | — | 2020-04-16 | 2020-05-28 | |
| 8-K | — | 2020-03-18 | 2020-03-13 | |
| 10-K | — | 2020-03-10 | 2019-12-31 | |
| 8-K | — | 2020-03-10 | — | |
| 8-K | — | 2020-02-24 | 2020-02-18 |
Showing 101–119 of 119 filings
Key facts
CIK
1377121
CUSIP
74366E102
13F (30d)
30 filings
30 filers
Visit website
Investor relations